Tim-3 and Tim-4 as the potential targets for antitumor therapy
about
Novel cancer antigens for personalized immunotherapies: latest evidence and clinical potentialThe significance of TIMD4 expression in clear cell renal cell carcinoma.Tim-3 as a diagnostic and prognostic biomarker of osteosarcoma.Effects of Tim-3 silencing on the viability of fibroblast-like synoviocytes and lipopolysaccharide-induced inflammatory reactionsConcordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy.TIM-3, a promising target for cancer immunotherapy
P2860
Tim-3 and Tim-4 as the potential targets for antitumor therapy
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Tim-3 and Tim-4 as the potential targets for antitumor therapy
@ast
Tim-3 and Tim-4 as the potential targets for antitumor therapy
@en
Tim-3 and Tim-4 as the potential targets for antitumor therapy
@nl
type
label
Tim-3 and Tim-4 as the potential targets for antitumor therapy
@ast
Tim-3 and Tim-4 as the potential targets for antitumor therapy
@en
Tim-3 and Tim-4 as the potential targets for antitumor therapy
@nl
prefLabel
Tim-3 and Tim-4 as the potential targets for antitumor therapy
@ast
Tim-3 and Tim-4 as the potential targets for antitumor therapy
@en
Tim-3 and Tim-4 as the potential targets for antitumor therapy
@nl
P2860
P1476
Tim-3 and Tim-4 as the potential targets for antitumor therapy
@en
P2093
Zhihua Ruan
P2860
P304
P356
10.1080/21645515.2015.1056953
P407
P577
2015-01-01T00:00:00Z